Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke "CLEAR-ER"


Phase 2 Results



  • Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, Sucharew H, Brooks CE, Crocco TJ, Gutmann L, Hemmen TM, Kasner SE, Kleindorfer D, Knight WA, Martini S, McKinney JS, Meurer WJ, Meyer BC, Schneider A, Scott PA, Starkman S, Warach S, Broderick JP; CLEAR-ER Investigators. Combined Approach to Lysis Utilizing Eptifibatide and recombinant tissue plasminogen activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial. Stroke. 2013 Sep;44(9):2381-7. doi: 10.1161/STROKEAHA.113.001059. Epub 2013 Jul 25. Pubmed ID:23887841
  • Barreto AD, Pedroza C, Grotta JC. Adjunctive medical therapies for acute stroke thrombolysis: is there a CLEAR-ER choice? Stroke. 2013 Sep;44(9):2377-9. doi: 10.1161/STROKEAHA.113.001830. Epub 2013 Jul 25. Pubmed ID:23887845

Related Links

Sources for Trial Information